GLP1 Receptor Agonist Use Does Not Seem to Increase Risk for Thyroid Cancer
No increased risk for thyroid cancer seen with use of GLP1 receptor agonist versus DPP4 inhibitor use, SGLT2 inhibitor use
Seafood Consumption Tied to ‘Forever Chemical’ Exposure Risk
Consumers of seafood purchased in a local Northeastern U.S. market may be exposed to potentially risky PFAS concentrations
Few Cancer Survivors Fully Adherent to ACS Nutrition and Physical Activity Guidelines
Factors associated with greater adherence include female sex, older age, Black race, higher educational level
Higher Dietary Quality at Breast Cancer Diagnosis Linked to Lower CVD Risk
Dietary Approaches to Stop Hypertension diet may provide the most benefit for CVD
Aspirin May Enhance Immunosurveillance Against Colorectal Cancer
Aspirin users have nodal metastases significantly less often, higher infiltration of tumor-infiltrating lymphocytes
New Prostate Cancer Urine Test Has High Diagnostic Accuracy
Higher AUROC seen for 18-gene MPS2 model compared with current guideline-endorsed biomarkers
EPA Designates Two ‘Forever Chemicals’ as Hazardous
Alecensa Approved as First and Only ALK Inhibitor for Non-Small Cell Lung Cancer
Drug approved for patients with ALK-positive, early-stage cancer who undergo surgery to remove their tumor
Mortality Down for Rectal Cancer Surgery at NAPRC-Accredited Hospitals
Lower rates of 30-day complications also observed at accredited hospitals
Review Explores Cutaneous Manifestations of Myelodysplastic Syndrome
Common manifestations include neutrophilic dermatoses, vasculitis, granulomatous, connective tissue disease
